Health In Tech growth chief sells 1,667 shares

The sale was made under a Rule 10b5-1 plan adopted June 11, 2026; direct holdings afterward were 171,993 shares.

Available on EDGAR 11/05/2026 - 04:32 PM EST Accepted by SEC EDGAR 11/05/2026 - 04:30 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Health In Tech, Inc. Chief Growth Officer Zain Syed Hasan sold 1,667 shares of Class A Common Stock on November 3, 2026, at a weighted average price of $0.55 per share. The sale was made under a Rule 10b5-1 trading plan adopted June 11, 2026. His direct holdings after the sale were 171,993 shares, including 153,333 restricted shares and 18,660 unrestricted shares.

Insider Trade Summary 10b5-1

Net Seller: 1,667 shares

Net Sell 1 txn

Insider Hasan Zain Syed

Role Chief Growth Officer

Sold 1,667 shs ($916.85)

Share of Position Sold 0.96%

Type	Security	Shares	Price	Value
Sale	Class A Common Stock F1, F2, F3	1,667	$0.55	$916.85

Holdings After Transaction: Class A Common Stock — 171,993 shares (Direct)

Holdings Before and After: Class A Common Stock, 173,660 to 171,993 shares (Direct)

Footnotes (3)

1. F1. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2026.
2. F2. The reported price in Column 4 is a weighted average price. The reporting person undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price underlying the weighted average price disclosed in this footnote.
3. F3. Includes 153,333 restricted shares of Class A Common Stock and 18,660 unrestricted shares of Class A Common Stock.

Key Figures

Shares sold: 1,667 shares Weighted average sale price: $0.55 per share Direct holdings after sale: 171,993 shares +2 more

5 metrics

Shares sold 1,667 shares Class A Common Stock sale on November 3, 2026

Weighted average sale price $0.55 per share November 3, 2026 sale

Direct holdings after sale 171,993 shares Following the November 3, 2026 transaction

Restricted shares held 153,333 shares Included in direct holdings after the transaction

Unrestricted shares held 18,660 shares Included in direct holdings after the transaction

Key Terms

Rule 10b5-1 trading plan, weighted average price, restricted shares

3 terms

Rule 10b5-1 trading plan regulatory

"pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average price financial

"The reported price in Column 4 is a weighted average price"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

restricted shares financial

"Includes 153,333 restricted shares of Class A Common Stock"

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many HIT shares did the chief growth officer sell?

Health In Tech Chief Growth Officer Zain Syed Hasan sold 1,667 Class A Common Stock shares on November 3, 2026, at a weighted average price of $0.55 per share. The sale was under a Rule 10b5-1 trading plan adopted June 11, 2026; he directly held 171,993 shares afterward.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hasan Zain Syed

(Last) (First) (Middle)

701 S. COLORADO AVE, SUITE 1

(Street)

STUART FLORIDA 34994

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Health In Tech, Inc. [ HIT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Growth Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	11/03/2026		S(1)		1,667	D	$0.55(2)	171,993(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2026.

2. The reported price in Column 4 is a weighted average price. The reporting person undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price underlying the weighted average price disclosed in this footnote.

3. Includes 153,333 restricted shares of Class A Common Stock and 18,660 unrestricted shares of Class A Common Stock.

	/s/ Lori Babcock, as attorney-in-fact for Zain Hasan	11/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)